Javascript must be enabled to continue!
Isolation and Characterization of Influenza Virus B (Lee Strain)
View through CrossRef
Summary
A particulate component possessing the biological properties of the influenza virus B (Lee strain), as determined by chicken red blood cell agglutination, precipitation, complement fixation and infectivity for chick embryos, has been isolated in purified preparations from the chorio-allantoic fluid of chick embryos. Concentration and purification were accomplished by adsorption on and elution from chicken red blood cells followed by ultracentrifugation of the eluate at 27,000 g for 1 hour. Electron micrographs of the concentrates revealed circular or ovoid images, measurements of which indicated an average particle diameter of 97.3 mμ. In diagrams of sedimentation-velocity there was present a single slightly diffuse boundary corresponding to a sedimentation-constant of S20° = 832 × 10−13. The probable relation of diffuseness of the boundary to variation in particle size in electron micrographs has been discussed in connection with similar findings with influenza virus A.
The yield of virus from 6,600 ml of chorio-allantoic fluid was 137 mg or 2.1 mg per 100 ml of the fluid. On the basis of nitrogen, the degree of concentration was about 20 times and on volume, practicable for working conditions, 150 times. Preliminary analysis indicated that the virus is a complex containing 21 per cent fat-solvent extractive of which 5.7 per cent are neutral fat, 10.2 per cent phospholipid and 5.1 per cent cholesterol. The non-lipid fraction was 66 per cent of the whole virus and gave the qualitative tests for protein and for desoxy-pentose. It contained 0.44 per cent phosphorus, which, if all was associated with nucleic acid, indicated the possible presence of 3.5 per cent nucleic acid of the desoxypentose type in the whole virus. The total phosphorus of the whole virus was 0.7 per cent. The total carbohydrate of the whole virus was 9 per cent, an amount greatly in excess of that accounted for in nucleic acid. The specific volume determined by pyknometer was 0.865.
A comparison of the characters of the influenza virus B with those found for influenza virus A reveals certain differences between the two agents. The influenza virus A appeared to consist principally of bean- or kidney-shaped particles whereas the particles of influenza virus B were more nearly spherical bodies. An average diameter of 77.6 mμ was obtained from electron micrographs of the influenza virus A, and the sedimentation-constant was S20° = 724 × 10−13. The diameter of the influenza virus A particles calculated from the density and sedimentation-constant, assuming a spherical shape, was 80 mμ. A similar calculation for influenza virus B gave a value of 99.8 mμ, for the particle diameter. The differences in the respective sedimentation-constants and the diameters of influenza viruses A and B, determined from sedimentation-velocity and electron micrographs, were of a magnitude which indicated a significant difference in the sizes of the two agents.
Oxford University Press (OUP)
Title: Isolation and Characterization of Influenza Virus B (Lee Strain)
Description:
Summary
A particulate component possessing the biological properties of the influenza virus B (Lee strain), as determined by chicken red blood cell agglutination, precipitation, complement fixation and infectivity for chick embryos, has been isolated in purified preparations from the chorio-allantoic fluid of chick embryos.
Concentration and purification were accomplished by adsorption on and elution from chicken red blood cells followed by ultracentrifugation of the eluate at 27,000 g for 1 hour.
Electron micrographs of the concentrates revealed circular or ovoid images, measurements of which indicated an average particle diameter of 97.
3 mμ.
In diagrams of sedimentation-velocity there was present a single slightly diffuse boundary corresponding to a sedimentation-constant of S20° = 832 × 10−13.
The probable relation of diffuseness of the boundary to variation in particle size in electron micrographs has been discussed in connection with similar findings with influenza virus A.
The yield of virus from 6,600 ml of chorio-allantoic fluid was 137 mg or 2.
1 mg per 100 ml of the fluid.
On the basis of nitrogen, the degree of concentration was about 20 times and on volume, practicable for working conditions, 150 times.
Preliminary analysis indicated that the virus is a complex containing 21 per cent fat-solvent extractive of which 5.
7 per cent are neutral fat, 10.
2 per cent phospholipid and 5.
1 per cent cholesterol.
The non-lipid fraction was 66 per cent of the whole virus and gave the qualitative tests for protein and for desoxy-pentose.
It contained 0.
44 per cent phosphorus, which, if all was associated with nucleic acid, indicated the possible presence of 3.
5 per cent nucleic acid of the desoxypentose type in the whole virus.
The total phosphorus of the whole virus was 0.
7 per cent.
The total carbohydrate of the whole virus was 9 per cent, an amount greatly in excess of that accounted for in nucleic acid.
The specific volume determined by pyknometer was 0.
865.
A comparison of the characters of the influenza virus B with those found for influenza virus A reveals certain differences between the two agents.
The influenza virus A appeared to consist principally of bean- or kidney-shaped particles whereas the particles of influenza virus B were more nearly spherical bodies.
An average diameter of 77.
6 mμ was obtained from electron micrographs of the influenza virus A, and the sedimentation-constant was S20° = 724 × 10−13.
The diameter of the influenza virus A particles calculated from the density and sedimentation-constant, assuming a spherical shape, was 80 mμ.
A similar calculation for influenza virus B gave a value of 99.
8 mμ, for the particle diameter.
The differences in the respective sedimentation-constants and the diameters of influenza viruses A and B, determined from sedimentation-velocity and electron micrographs, were of a magnitude which indicated a significant difference in the sizes of the two agents.
Related Results
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
Please cite this paper as: Borders‐Hemphill and Mosholder (2012) U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic. Influenza and...
Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017
Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017
Abstract
Background
The influenza virus spreads rapidly around the world in seasonal epidemics, resulting in significant morbidity and mortality. In...
Comparative characteristics of clinical, laboratory and instrumental indicators in children with seasonal influenza depending on the virus strain
Comparative characteristics of clinical, laboratory and instrumental indicators in children with seasonal influenza depending on the virus strain
Introduction. According to the literature, it is known that clinical signs and symptoms of influenza may differ depending on age, the state of the human immune system, the serot...
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
Antiviral therapy such as Oseltamivir has been recommended for hospitalized children with suspected and confirmed influenza for almost 20 years. The therapy is officially authorize...
A severe 2017 influenza season dominated by influenza A(H3N2), Victoria, Australia
A severe 2017 influenza season dominated by influenza A(H3N2), Victoria, Australia
Surveillance for influenza-like illness (ILI) and laboratory-confirmed influenza in Victoria, Australia is undertaken jointly by the Victorian Infectious Diseases Reference Laborat...
Pudilan xiaoyan oral liquid (PDL) inhibit the replication of influenza A virus through regulating TLR3/MyD88 signaling pathway
Pudilan xiaoyan oral liquid (PDL) inhibit the replication of influenza A virus through regulating TLR3/MyD88 signaling pathway
Abstract
Background
Pudilan Xiaoyan Oral Liquid (PDL) as a famous Chinese patent medicine has been widely used for treating upper respiratory tract infection. However, the...
Vaksin Influenza dan COVID-19 : sebuah tinjauan
Vaksin Influenza dan COVID-19 : sebuah tinjauan
<p>Pendahuluan: SARS-CoV-2 merupakan agen virus penyebab COVID-19, penyakit yang menjadi wabah secara global. Gejala infeksi COVID-19 beragam, sebagian besar dengan derajat r...
Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains
Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains
ABSTRACT
Seasonal influenza virus infections continue to cause significant disease each year, and there is a constant threat of the emergence of reassortant influenza str...

